Paper6979554
Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.
Alcocer-Varela J and 1 other. J Clin Invest, 1982. Cited by 407 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. Papers, record 6979554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6979554
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin-2 | Major topic |
| Lupus Erythematosus, Systemic | Major topic |
| Lymphocyte Activation | Major topic |
| Lymphokines | Major topic |
| T-Lymphocytes | Major topic |
| Absorption | |
| Adult | |
| Cells, Cultured | |
| Female | |
| Humans | |
| Immunoglobulin G | |
| Immunoglobulin M | |
| Male | |
| Middle Aged | |
| Phytohemagglutinins |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 849,643 | Serum effects of mitogenic reactivity in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Technical considerations and lack of correlation with anti-lymphocyte antibodies. | Clin Exp Immunol | 1977 | https://conductscience.org/library/papers/849643 | PubMed |
| 2 | 307,029 | T cell growth factor: parameters of production and a quantitative microassay for activity. | J Immunol | 1978 | https://conductscience.org/library/papers/307029 | PubMed |
| 3 | 153,913 | The cellular basis of the impaired autologous mixed lymphocyte reaction in patients with systemic lupus erythematosus. | J Clin Invest | 1979 | https://conductscience.org/library/papers/153913 | PubMed |
| 4 | 311,785 | Decreased circulating thymus-derived cells with receptors for the Fc portion of immunoglobulin G in systemic lupus erythematosus. | J Clin Invest | 1978 | https://conductscience.org/library/papers/311785 | PubMed |
| 5 | 311,787 | Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction. | J Clin Invest | 1979 | https://conductscience.org/library/papers/311787 | PubMed |
| 6 | 109,511 | Molecular and quantitative analysis of helper T cell-replacing factors on the induction of antigen-sensitive B and T lymphocytes. | J Immunol | 1979 | https://conductscience.org/library/papers/109511 | PubMed |
| 7 | 376,727 | Antibody penetration into living cells. II. Anti-ribonucleoprotein IgG penetrates into Tgamma lymphocytes causing their deletion and the abrogation of suppressor function. | J Immunol | 1979 | https://conductscience.org/library/papers/376727 | PubMed |
| 8 | 389,249 | Glucocorticoids and immune responses. | Arthritis Rheum | 1979 | https://conductscience.org/library/papers/389249 | PubMed |
| 9 | 6,966,190 | Continued growth of functional human T lymphocytes: production of human T-cell growth factor. | Cell Immunol | 1980 | https://conductscience.org/library/papers/6966190 | PubMed |
| 10 | 6,447,163 | Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function. | J Clin Invest | 1980 | https://conductscience.org/library/papers/6447163 | PubMed |
| 11 | 6,998,486 | Heterogeneity of the spontaneously expanded and mitogen-induced generation of suppressor cell function of T cells on B cells in systemic lupus erythematosus. | Arthritis Rheum | 1980 | https://conductscience.org/library/papers/6998486 | PubMed |
| 12 | 7,000,669 | Cellular origins and targets of costimulator (IL2). | Immunol Rev | 1980 | https://conductscience.org/library/papers/7000669 | PubMed |
| 13 | 7,000,827 | Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. | J Clin Invest | 1980 | https://conductscience.org/library/papers/7000827 | PubMed |
| 14 | 6,969,594 | Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody. | Arthritis Rheum | 1980 | https://conductscience.org/library/papers/6969594 | PubMed |
| 15 | 7,006,707 | Human T-lymphocyte growth factor: regulation of growth and function of T lymphocytes. | Blood | 1981 | https://conductscience.org/library/papers/7006707 | PubMed |
| 16 | 6,970,755 | Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. | J Clin Invest | 1981 | https://conductscience.org/library/papers/6970755 | PubMed |
| 17 | 6,971,333 | Human postthymic precursor cells in health and disease. II. Their loss and dysfunction in systemic lupus erythematosus and their partial correction with serum thymic factor. | J Clin Lab Immunol | 1981 | https://conductscience.org/library/papers/6971333 | PubMed |
| 18 | 6,454,746 | T cell growth factor abrogates concanavalin A-induced suppressor cell function. | J Exp Med | 1981 | https://conductscience.org/library/papers/6454746 | PubMed |
| 19 | 6,456,304 | The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines. | J Immunol | 1981 | https://conductscience.org/library/papers/6456304 | PubMed |
| 20 | 6,456,309 | Immune responses to hapten-modified self and their regulation in normal individuals and patients with SLE. | J Immunol | 1981 | https://conductscience.org/library/papers/6456309 | PubMed |
Cited by139
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 407 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,756,292 | Restoring B cell intrinsic tolerance to lupus autoimmunity: a rational strategy for lupus treatment. | Front Immunol | 2026 | https://conductscience.org/library/papers/41756292 | PubMed |
| 40,524,030 | Immunometabolism in systemic lupus erythematosus. | Nat Rev Rheumatol | 2025 | https://conductscience.org/library/papers/40524030 | PubMed |
| 40,402,317 | IL-2 detected by flow cytometry and its significance in systemic lupus erythematosus. | Clin Rheumatol | 2025 | https://conductscience.org/library/papers/40402317 | PubMed |
| 39,558,087 | Roles of TULA-family proteins in T cells and autoimmune diseases. | Genes Immun | 2025 | https://conductscience.org/library/papers/39558087 | PubMed |
| 39,425,027 | Hypothetical proteins of chicken-isolated Limosilactobacillus reuteri subjected to in silico analyses induce IL-2 and IL-10. | Genes Nutr | 2024 | https://conductscience.org/library/papers/39425027 | PubMed |
| 37,445,926 | Endosome Traffic Modulates Pro-Inflammatory Signal Transduction in CD4+ T Cells-Implications for the Pathogenesis of Systemic Lupus Erythematosus. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37445926 | PubMed |
| 37,240,014 | UBASH3A Interacts with PTPN22 to Regulate IL2 Expression and Risk for Type 1 Diabetes. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37240014 | PubMed |
| 36,459,355 | Vitamin D Presented In Vitro Immunomodulatory Property on T Lymphocyte-Related Cytokines in Systemic Lupus Erythematosus. | Inflammation | 2023 | https://conductscience.org/library/papers/36459355 | PubMed |
| 36,203,602 | Increased sIL-2Rα leads to obstruction of IL-2 biological function and Treg cells differentiation in SLE patients via binding to IL-2. | Front Immunol | 2022 | https://conductscience.org/library/papers/36203602 | PubMed |
| 36,015,084 | Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/36015084 | PubMed |
| 35,626,662 | Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis. | Cells | 2022 | https://conductscience.org/library/papers/35626662 | PubMed |
| 35,523,941 | The deacetylase SIRT2 contributes to autoimmune disease pathogenesis by modulating IL-17A and IL-2 transcription. | Cell Mol Immunol | 2022 | https://conductscience.org/library/papers/35523941 | PubMed |
| 35,326,431 | T Cells, Interleukin-2 and Systemic Lupus Erythematosus-From Pathophysiology to Therapy. | Cells | 2022 | https://conductscience.org/library/papers/35326431 | PubMed |
| 34,728,817 | Interleukin-2 and regulatory T cells in rheumatic diseases. | Nat Rev Rheumatol | 2021 | https://conductscience.org/library/papers/34728817 | PubMed |
| 34,352,946 | Disease presentation and surgical treatment of patients with foreign-body granulomas and ASIA syndrome: case series. | Arch Plast Surg | 2021 | https://conductscience.org/library/papers/34352946 | PubMed |
| 33,496,881 | Immune regulation in renal inflammation. | Cell Tissue Res | 2021 | https://conductscience.org/library/papers/33496881 | PubMed |
| 29,868,033 | Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus. | Front Immunol | 2018 | https://conductscience.org/library/papers/29868033 | PubMed |
| 29,854,836 | The Involvement of MicroRNAs in Modulation of Innate and Adaptive Immunity in Systemic Lupus Erythematosus and Lupus Nephritis. | J Immunol Res | 2018 | https://conductscience.org/library/papers/29854836 | PubMed |
| 29,670,626 | Prophylactic and Therapeutic Effects of Interleukin-2 (IL-2)/Anti-IL-2 Complexes in Systemic Lupus Erythematosus-Like Chronic Graft-Versus-Host Disease. | Front Immunol | 2018 | https://conductscience.org/library/papers/29670626 | PubMed |
| 29,038,617 | Patients with Systemic Lupus Erythematosus Show Increased Levels and Defective Function of CD69+ T Regulatory Cells. | Mediators Inflamm | 2017 | https://conductscience.org/library/papers/29038617 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL2 | 3,558 | PubTator's text mining | https://conductscience.org/library/genes/3558 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6979554
GET https://conductscience.org/api/papers/v1/6979554/references?page=2